AgingResearch.NewsJoin free

B cell depletion therapy

Intervention

1 paper1 finding

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Funders: Multiple Sclerosis Society and 2 more
  • Humans1

Outcomes

1

p16INK4a

downin humans1

1 study

  1. B cell depletion therapy decreases p16INK4a in humans.

    “in this age group B cell depletion therapy was associated with lower expression levels”

    Humansmultiple sclerosis

    Senescence marker p16INK4a expression in patients with multiple sclerosis

    Multiple sclerosis and related disorders11 Feb 2024

More on p16INK4a

Latest

Related